K2 types and their contents: Are product disclosures true?

American Journal of Emergency Medicine

Volumn 33, Issue 6, 2015, Pages 845-846

  Hassen, Getaw Worku ^a   Roy, Asha A ^a   Becerra, Ivan ^a   Diep, Monica ^b   Scherbakova, Ioana ^b   Denonno, Lara ^c   Chirurgi, Roger ^a   McCorkell, Peter ^a   Bulbena Cabre, Andrea ^a   Dunn, Norma ^a  

^a METROPOLITAN HOSPITAL CENTER   (United States)

^b Metropolitan Hospital Center ^*  (United States)

^c HARLEM HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; K2 DRUG; UNCLASSIFIED DRUG; STREET DRUG;

EXPOSURE; HUMAN; INCENSE; LETTER; MENTAL DISEASE; PACKAGING; PRIORITY JOURNAL; PRODUCT SAFETY; WITHDRAWAL SYNDROME; CHEMISTRY; DRUG LABELING; INTERPERSONAL COMMUNICATION;

CANNABINOIDS; DISCLOSURE; DRUG LABELING; HUMANS; STREET DRUGS;

EID: 84930925161     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2015.03.037     Document Type: Letter

References (11)

1. J.B. Zawilska, and J. Wojcieszak Spice/K2 drugs-more than innocent substitutes for marijuana Int J Neuropsychopharmacol 17 3 2014 509 525
2. Policy, T.W.H.O.o.N.D.C., Synthetic drugs (a.k.a K2, Spice, Bath Salts etc.)
3. T.U. Jarbe, and R.S. Gifford "Herbal incense": designer drug blends as cannabimimetics and their assessment by drug discrimination and other in vivo bioassays Life Sci 97 1 2014 64 71
4. AA Roy, L DeNonno, I Becerra, R Chirurgi, P McCorkell, and GW Hassen The rise in K2 use with varying clinical symptoms and the potential for ED crowding Am J Emerg Med 2014 Dec 19 [Epub ahead of print]
5. M.S. Castaneto, D.A. Gorelick, N.A. Desrosiers, R.L. Hartman, S. Pirard, and M.A. Huestis Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications Drug Alcohol Depend 144C 2014 12 41
6. C.D. Rosenbaum, S.P. Carreiro, and K.M. Babu Here today, gone tomorrow...and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines J Med Toxicol 8 1 2012 15 32
7. V. Macfarlane, and G. Christie Synthetic cannabinoid withdrawal: a new demand on detoxification services Drug Alcohol Rev 34 2015 147 153
8. J. McLaren, W. Swift, P. Dillon, and S. Allsop Cannabis potency and contamination: a review of the literature Addiction 103 7 2008 1100 1109
9. L. Fattore, and W. Fratta Beyond THC: The New Generation of Cannabinoid Designer Drugs Front Behav Neurosci 5 2011 60
10. O. Cottencin, B. Rolland, and L. Karila New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature Curr Pharm Des 20 25 2014 4106 4111
11. W.E. Fantegrossi, J.H. Moran, A. Radominska-Pandya, and P.L. Prather Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Delta(9)-THC: mechanism underlying greater toxicity? Life Sci 97 1 2014 45 54